873950-18-6 Usage
Description
Atorvastatin Cyclic (Fluorophenyl) Impurity is a white to off-white solid that is a photodegradation product of Atorvastatin, a widely used cholesterol-lowering drug. It is also an analyte in the simultaneous quantitative determination of metoprolol, atorvastatin, and ramipril.
Uses
Used in Pharmaceutical Industry:
Atorvastatin Cyclic (Fluorophenyl) Impurity is used as a reference material for the development and validation of analytical methods in the pharmaceutical industry. It helps in the simultaneous quantitative determination of metoprolol, atorvastatin, and ramipril, which are important drugs used for treating cardiovascular diseases.
Used in Quality Control:
Atorvastatin Cyclic (Fluorophenyl) Impurity is used as a quality control standard to ensure the purity and potency of Atorvastatin and other related drugs. It helps in monitoring the presence of impurities and degradation products in the final drug product, ensuring the safety and efficacy of the medication.
Used in Research and Development:
Atorvastatin Cyclic (Fluorophenyl) Impurity is used as a research tool in the development of new drugs and drug delivery systems. It provides valuable insights into the chemical properties, stability, and degradation pathways of Atorvastatin and related compounds, aiding in the design of more effective and safer medications.
Check Digit Verification of cas no
The CAS Registry Mumber 873950-18-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,7,3,9,5 and 0 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 873950-18:
(8*8)+(7*7)+(6*3)+(5*9)+(4*5)+(3*0)+(2*1)+(1*8)=206
206 % 10 = 6
So 873950-18-6 is a valid CAS Registry Number.
873950-18-6Relevant articles and documents
OXIDATIVE DEGRADATION PRODUCTS OF ATORVASTATIN CALCIUM
-
Page/Page column 15, (2008/06/13)
The present invention relates to oxidative degradation products of atorvastatin calcium and the process of the preparation thereof. The present invention also relates to atorvastatin calcium substantially free of oxidative degradation products and the pha
